Genomics of microbial pathogens and host–pathogen interactions by unknown
ABSTRACTS
Genomics of microbial pathogens and host–pathogen interactions
 Human Genome Organisation (HUGO) International Limited 2009
020: Predicting protein–protein interactions
from metagenomics datasets
Tun Kyaw, Pawan Dhar
RIKEN Advanced Research Institute, 1-7-22 Suehiro-cho,
Tsurumi-ku, Japan
It is now understood that even completely-sequenced genomes present
only a partial snapshot of cellular inventory and processes. The bulk of
processes happen at the RNA and protein interaction levels. Since
interaction information of metagenome data is generally not available,
people have used genome sequence to predict protein interactions and
functions. However, proteins rarely act alone. They frequently assemble
with other proteins to enable cellular functions. With millions of new
genes identified through metagenomics studies, the task of identifying
proteins, their interactions and their function, is truly enormous. We have
embarked upon the mission of virtually constructing molecular networks
for organisms for which genome sequence is the only available data. As a
first step, we are focusing on protein–protein interactions. We hope to
implement the modules in the iMetaSys workflow. The module takes
input proteins as single FASTA format and outputs as simple interaction
format (SIF). In addition, we hope to use network description for anno-
tating protein functions. Although our initial results are promising, the
sheer complexity of information is likely to generate false positives. To
overcome that we hope to conduct functional metagenomics experiments
to reconstruct a reasonably accurate picture of molecular interactions,
both within and between organisms.
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Leprosy represents a significant health burden and remains endemic
in several parts of the world. There is evidence that Toll-like receptor
1 (TLR1) mediates immune response to Mycobacterium leprae, the
causative agent for leprosy. We hypothesize that genetic polymor-
phisms in the region are associated with susceptibility to leprosy.
Using Sequenom MassArray MALDI-TOF primer extension assay,
we have genotyped 15 single nucleotide polymorphisms (SNPs) in the
TLR 10-6-1 gene cluster in Indian samples. Strong evidence of
association was obtained at a non-synonymous SNP (rs5743618) in
TLR1 where the G allele was associated with significant protection in
the case–control samples (OR = 0.41, P = 0.0000056). Significant
associations were also observed for other SNPs in the region. In
conclusion, we have demonstrated that genetic polymorphisms in the
TLR 10-6-1 gene cluster are strongly associated with susceptibility to
leprosy, and our results suggested that TLR1 may play a crucial role
in the immunity against leprosy.
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Virulent strains of Mycobacterium tuberculosis (MTB) induce
‘alternative activation’ of the host macrophage. Studies using inha-
lable microparticles with or without a payload of anti-tuberculosis
drugs have indicated that such microparticles can rescue MTB-
infected macrophages from alternative activation and induce oxida-
tive radicals, Th1 cytokines and apoptosis. A genome-wide
transcription analysis (Affymetrix HG-U133 Plus 2.0 DNA micro-
array) of THP-1 derived macrophages was undertaken after exposing
them to infection with 10 MOI of MTB H37Rv at 0, 12 and 24 h post
infection. Parallel groups were treated with drugs in solution, drug-
containing microparticles or blank microparticles. About 1,500 genes
were differentially upregulated and about 500 genes differentially
downregulated in response to various modes of treatment. Variations
were also observed in the kinetics of gene expression. Cluster analysis
indicated activation of several pathways related to innate immune
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response (cytokines, chemokines, receptors and ligands), apoptosis,
cytoskeleton and membrane remodeling, general metabolism and
general housekeeping. Some of these results were validated at the
functional level, by studying enzyme activities, concentrations and
time-courses of effector molecules and rates/extents of apoptosis. The
results compared well with published reports on transcription
response of human macrophages to MTB infection. These results
permitted a novel analysis of tripartite interaction between host,
pathogen and drug. Such analysis is important from an appreciation of
the fact that concurrent chemotherapy is the norm in tuberculosis, but
the outcome of chemotherapy is likely to be significantly affected by
the contribution of the host response to both infection and drug
treatment. Our data provide a basis for considering the relative con-
tributions of the macrophage response to infection and drug treatment.
These data also indicate the ability of our proposed drug delivery
system to induce beneficial host responses. Finally, the data offer
insight into manifestations of drug toxicity in the host cell, and its
possible impact on the host response.
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Although H. pylori has been connected to gastric cancer, it has never
been seen as a big threat to human health in the South Asian countries
and particularly in India. This prompted us to look into the population
structure of H. pylori in India. We found that it shares genetic origins
as well as its trajectory of virulence genes with the western strains. A
series of putative virulence factors which are also abundant in Indian
isolates, were characterized by our group. These virulence factors are
encoded by the genomic plasticity region genes which constitute a
putative type IV secretion system believed to be acquired horizon-
tally. Two of these virulence factors (JH940 and HP986) potentially
interacted with the human immune system under in vitro conditions.
The HP986 appears to be involved in Helicobacter persistence. Most
persistent microbes seemingly evolve strategies to foil host responses
and gain a niche. However, it seems that there is fine tuning between
microbial immune evasion and maintenance of the growth fitness. For
example, H. pylori both downregulates T-cell responses through the
VacA mediated cell cycle arrest, and upregulates mucosal proin-
flammatory pathways by CagA. Surprisingly in our studies, HP986
appears to be able to perform both the immune stimulatory and
immune evasion tasks single handedly.
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Plasmodium vivax long thought to be a benign parasite has recently
been shown to cause severe manifestations (1,2) which include
cerebral malaria, hepatic failure, renal failure etc. which are associ-
ated with sequestration linked phenomena in Plasmodium falciparum
infections. The present study uses global expressions analysis of
P. vivax parasites involved in severe manifestations and attempts to
correlate the data with expression analysis of the human PBMC from
the same cases. Initial data shows up-regulation of 1,594 genes
(PlasmoDB) using pooled severe P. vivax samples in comparison to
non severe manifestations.
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Helicobacter pylori is a gastric pathogen that chronically infects the
gastric mucosa of more than half of the world’s population. Two
polymorphisms -511C[T and -31C[T in the IL1B promoter have
been suggested as potential susceptibility loci for Helicobacter pylori
associated gastro duodenal diseases. Gastrin, one of the hormones
that regulate gastric acid secretion, is involved in the pathogenesis of
gastroduodenal ulcerations. The present study investigated the effect
of IL1B promoter polymorphism on the transcriptional activity of the
human gastrin promoter in a gastric epithelial cell line, AGS, and
analyzed the underlying molecular mechanisms. Treatment of AGS
with IL1B resulted in a 20-fold reduction in gastrin expression.
Analysis revealed that IL1B represses gastrin through TAK1, TAB1
that ultimately up regulates NFkB. A 40% release of IL1B mediated
gastrin repression, as a result of inhibition of NFkB translocation,
further suggested the presence of NFkB independent pathway. It was
observed that IL1B up regulates Smad7, which inhibits gastrin
expression by sixfolds. These results were also validated invivo,
where, at least a threefold lower expression of Smad7 and NFkB in
H. pylori an infected individual with ulcer compared to infected
asymptomatic individuals was observed. Analysis of the gastrin
promoter suggests the involvement of repressor complexes consist-
ing of NCOR and HDAC1 in IL1B mediated gastrin repression. The
differential effect of IL1B promoter variants on its transcription and
subsequent regulation on gastrin expression was also investigated.
There was almost threefold increase in IL1B expression when AGS
cells were transfected with -31TIL1B expression construct in com-
parison to -31CIL1B. The -31TIL1B induced a twofold greater
repression of the gastrin luciferase activity compared to the
-31CIL1B. This signaling of the variant allele driven IL1B revealed
an almost 1.5-fold greater expression NFkB in the -31TIL1B trans-
fected AGS cells. Experiments with HDAC inhibitor also suggested
that at a particular dose, the repression on the gastrin promoter in
-31CIL1B-transfected cells was greater than in cells transfected with
-31TIL1B. The invitro study has, therefore, successfully reflected at
least part of the invivo scenario resulting from genetic
polymorphisms.
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